Related Experiment Video
Updated: May 5, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
TEVAR for type B aortic dissection in Japan
1Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, Aichi, 466-8550, Japan, ausui@med.nagoya-u.ac.jp.
Insights
Transcatheter Endovascular Aortic Repair (TEVAR) is increasingly used for acute and chronic type B aortic dissection in Japan. Data from 2001-2010 shows a rapid rise in TEVAR use, especially after 2008.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Medical Technology
Background:
- Type B aortic dissection requires effective treatment strategies for both acute and chronic cases.
- Transcatheter Endovascular Aortic Repair (TEVAR) is a minimally invasive option gaining traction globally.
- Current guidelines recommend TEVAR for complicated acute and chronic type B aortic dissection.
Purpose of the Study:
- To analyze the adoption and utilization trends of TEVAR for type B aortic dissection in Japan between 2001 and 2011.
- To compare TEVAR usage with traditional open surgery for acute and chronic type B aortic dissection.
Main Methods:
- Retrospective analysis of annual reports from the Japanese Association for Thoracic Surgery (2001-2011).
- Data extraction on the number of patients treated with TEVAR and open surgery for acute and chronic type B aortic dissection.
- Evaluation of trends in treatment modalities over the specified period.
Main Results:
- TEVAR use for acute type B aortic dissection increased significantly from 10 cases in 2001 to 76 in 2010.
- TEVAR use for chronic type B aortic dissection saw an abrupt rise in 2010, accounting for one-third of surgical procedures.
- Open surgery for chronic type B aortic dissection also increased, from 401 cases in 2001 to 947 in 2011.
Conclusions:
- TEVAR adoption for type B aortic dissection in Japan has shown a notable increase, particularly in recent years of the study period.
- Both TEVAR and open surgery are utilized, with TEVAR becoming a significant option for chronic dissections.
- A multidisciplinary approach is essential for selecting optimal surgical strategies for type B aortic dissection.
Abstract:
TEVAR is a new strategy for treating both acute and chronic type B aortic dissection. The JSC guidelines classify TEVAR as a Class I recommendation for cases of complicated acute type B dissection and a Class IIa recommendation for cases of chronic type B aortic dissection. While TEVAR has been primarily applied to treat complicated acute type B aortic dissection in Europe and the USA, the procedure remains an off-label treatment strategy for aortic dissection in Japan. The current state of TEVAR for type B aortic dissection in Japan from 2001 to 2011 is estimated in the annual reports of the Japanese Association for Thoracic Surgery. The number of acute type B aortic dissection patients treated with transluminal stent grafting increased rapidly after 2008, from 10 cases in 2001 to 76 cases in 2010. Meanwhile, the number acute type B aortic dissection patients treated with any type of surgery has increased gradually, from 100 cases in 2001 to 194 cases in 2009. The number of chronic type B aortic dissection patients treated with transluminal stent grafting increased abruptly in 2010, reaching 346 cases, which accounted for one-third of all surgical procedures for chronic type B aortic dissection. Furthermore, the number of open surgeries for chronic type B aortic dissection has also increased gradually, from 401 cases in 2001 to 947 cases in 2011. At present, open surgery, TEVAR and hybrid procedures are available to treat patients with type B aortic dissection. The use of a multidisciplinary team approach is mandatory when selecting the appropriate surgical strategy.
More Related Videos
07:02Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
05:31Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Thoracic Aorta
Mitral Stenosis III: Medical Management
Aneurysm III: Interprofessional Care